Lamivudine And Zidovudine Tablet, Film Coated
Product Images NDC 31722-739

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 31722-739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamivudinezidovudinestructure (Lamivudinezidovudinestructure1)

Chemical structure of Lamivudine, shown as a molecular diagram with labeled atoms including nitrogen, oxygen, sulfur, and hydroxyl groups.*

FDA Label Image

Amivudinezidovudinestructure2 (Lamivudinezidovudinestructure2)

Chemical structure of Lamivudine and Zidovudine, depicting the molecular arrangement of atoms characteristic to this combination drug.*

FDA Label Image

Lamivudinezidovudinecamberlogo (Lamivudinezidovudinecamberlogo)

FDA Label Image

Lamivudinezidovudinecontainerlabel (Lamivudinezidovudinecontainerlabel)

Label for Lamivudine and Zidovudine Tablets, USP, film coated, with a strength of 150 mg/300 mg. The 60-count bottle is labeled by Camber Pharmaceuticals, Inc. The label includes dosage strength details, storage instructions, a barcode, and manufacturer information including Hetero Labs Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.